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Abstract
Background: Affinity purification followed by mass spectrometry (AP/MS) is a widely used approach to identify
protein interactions and complexes. In multicellular organisms, the accurate identification of protein complexes by
AP/MS is complicated by the potential heterogeneity of complexes in different tissues. Here, we present an in vivo
biotinylation-based approach for the tissue-specific purification of protein complexes from Caenorhabditis elegans.
Tissue-specific biotinylation is achieved by the expression in select tissues of the bacterial biotin ligase BirA, which
biotinylates proteins tagged with the Avi peptide.
Results: We generated N- and C-terminal tags combining GFP with the Avi peptide sequence, as well as four BirA
driver lines expressing BirA ubiquitously and specifically in the seam and hyp7 epidermal cells, intestine, or neurons.
We validated the ability of our approach to identify bona fide protein interactions by identifying the known LGL-1
interaction partners PAR-6 and PKC-3. Purification of the Discs large protein DLG-1 identified several candidate
interaction partners, including the AAA-type ATPase ATAD-3 and the uncharacterized protein MAPH-1.1. We have
identified the domains that mediate the DLG-1/ATAD-3 interaction, and show that this interaction contributes to
C. elegans development. MAPH-1.1 co-purified specifically with DLG-1 purified from neurons, and shared limited
homology with the microtubule-associated protein MAP1A, a known neuronal interaction partner of mammalian
DLG4/PSD95. A CRISPR/Cas9-engineered GFP::MAPH-1.1 fusion was broadly expressed and co-localized with
microtubules.
Conclusions: The method we present here is able to purify protein complexes from specific tissues. We uncovered
a series of DLG-1 interactors, and conclude that ATAD-3 is a biologically relevant interaction partner of DLG-1.
Finally, we conclude that MAPH-1.1 is a microtubule-associated protein of the MAP1 family and a candidate
neuron-specific interaction partner of DLG-1.
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Background
Physical interactions between proteins are essential for
most, if not all, cellular processes. Hence, many small-
scale studies focus on finding binding partners of indi-
vidual proteins, and much effort has been put into iden-
tifying protein interactions on a large scale. One of the
most commonly used techniques to identify protein
complex components is affinity purification followed by
mass spectrometry (AP/MS). Insight into protein com-
plex composition obtained by AP/MS has already had a
major impact on our understanding of cellular processes
and signal transduction pathways [1]. Systematic AP/MS
efforts have mostly focused on single-cell systems, such
as yeast, bacteria, and cultured Drosophila melanogaster
cells [2–8]. In multicellular organisms, the composition
and function of protein complexes containing a particu-
lar protein of interest may differ between cell types or
tissues [9]. Purifying a protein from whole-animal lysates
will result in the identification of members of all com-
plexes, which complicates the interpretation of the bio-
logical meaning of the identified interactors. One
approach to overcome this limitation is to purify specific
tissues or cell types. However, the purification of specific
cell types from model organisms is challenging at the
scale needed for AP/MS.
Here, we present a method for the tissue-specific puri-
fication of protein complexes from the nematode Cae-
norhabditis elegans, based on cell type-specific
biotinylation. C. elegans is a widely used multicellular
model organism that contains many differentiated cell
types and tissues, including epithelia, neurons, and
muscle. Several studies have used AP/MS approaches to
purify C. elegans proteins and identify interaction part-
ners [10–22]. However, tissue-specific AP/MS ap-
proaches are not widely used.
To purify proteins from specific C. elegans tissues, we
adapted a system based on in vivo biotinylation of a pro-
tein of interest. In this approach, a protein of interest is
tagged with the 15-amino acid Avi-tag, which can be bi-
otinylated in vivo by the BirA biotin ligase from Escheri-
chia coli [23, 24]. The biotinylated bait protein and any
associated proteins are then purified with streptavidin-
coated beads, and their identities are determined by
mass spectrometry (MS). We demonstrate the applic-
ability of this approach by showing tissue-specific bio-
tinylation of Avi-tagged GFP, and by identifying the well-
known LGL-1/PAR-6/PKC-3 complex in two epithelial
tissues. We also identify a novel ubiquitous interaction
between the C. elegans Discs large protein DLG-1, and
the mitochondrial AAA-type ATPase ATAD-3. We con-
firm this surprising interaction by immunoprecipitation,
map the ATAD-3 interaction domain by yeast two-
hybrid assays, and confirm that this domain mediates
the interaction in vivo. Finally, we identify a candidate
neuron-specific interaction between DLG-1 and MAPH-
1.1, an uncharacterized protein that shares some se-
quence similarity with mammalian microtubule-
associated proteins MAP1A, MAP1B, and MAP1S. We
show that MAPH-1.1 is a microtubule-associated pro-
tein, and likely represents a C. elegans MAP1 family
member.
Results
A biotinylation-based tissue-specific protein purification
approach
To purify protein from specific tissues, we express Avi-
tagged proteins of interest from their native regulatory
sequences, while biotinylation in a specific tissue is ac-
complished by expressing BirA from tissue-specific pro-
moters (Fig. 1a). Expression of the bait protein from its
native regulatory sequences has several advantages.
First, expression will closely mimic the endogenous
expression pattern. Second, functionality of the tagged
protein can be tested by crossing the transgenic strain
with a strain carrying a mutation in the correspond-
ing gene. This simultaneously creates a strain that
does not express the untagged endogenous protein.
Finally, only a single transgenic strain needs to be
created, which can then be crossed to multiple BirA
driver strains to purify the protein of interest from
different tissues (Fig. 1a). As a first step, we generated
four distinct BirA driver strains expressing C. elegans
codon-optimized and Myc-tagged BirA ligase under
the control of different promoters. Two transgenic
strains express BirA in epithelial tissues, one ex-
presses BirA in the intestine from the elt-2 promoter,
and one expresses BirA in the seam and hyp7 epider-
mal cells from the wrt-2 promoter (wrt-2 expresses
predominantly in seam cells, with weak expression in
hyp7) [25]. In addition, we generated strains express-
ing BirA ubiquitously (using the rps-27 promoter),
and in neuronal cells (using the rgef-1 promoter). Re-
verse transcription (RT)-PCR of transgenic animals
expressing BirA from the rgef-1 promoter showed that
the BirA transgene was properly transcribed and
spliced (Additional file 1: Figure S1).
We designed N- and C-terminal tags consisting of
GFP and the Avi sequence, separated by two Tobacco
etch virus (TEV) cleavage sites, which we term the GTA
tag (for GFP, TEV, Avi) (Fig. 1b, Additional file 2:
Figure S2, and Additional file 3: Figure S3). The
presence of GFP enables the examination of the ex-
pression pattern and subcellular localization of the
protein of interest, either to confirm that the tagged
protein localizes as expected or to study the localization of
proteins whose localization pattern has not yet been (fully)
described. Tags combining GFP with affinity purification,
including a similar tag incorporating the Avi sequence,
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have been used successfully in C. elegans [10, 19].
The use of TEV cleavage sites is necessary to elimin-
ate biotinylated proteins naturally present in C. ele-
gans, which will also bind to streptavidin-coated
beads. TEV cleavage releases the bait protein and any
associated proteins from the beads, while naturally bi-
otinylated background proteins remain bound. GFP,
TEV, and Avi are separated by short flexible linkers
of five small amino acids, while GFP is separated
from the bait protein by a longer flexible linker of 13
small amino acids (Additional file 1: Figure S1 and
Additional file 2: Figure S2).
To add the tags to genes encoding proteins of interest,
we used fosmid recombineering, a homologous
recombination-based genetic engineering technique in
bacteria [26]. This approach enabled us to integrate the
tag into large regions of genomic DNA (30–40 kb) that
likely contain all the native regulatory sequences of the
gene of interest, including the promoter, 3′ UTR, and
introns (Fig. 1b).
An overview of the entire tagging and AP/MS proced-
ure is shown in Fig. 2. Transgenic strains expressing
GTA-tagged proteins are generated by germline injec-
tion of engineered fosmids, and the transgenic array is
integrated into the genome by gamma irradiation.
Transgenic strains expressing the GTA-tagged bait pro-
tein are then crossed to BirA-expressing strains. When-
ever possible, transgenic strains are also crossed to
strains carrying a mutation in the endogenous protein of
interest. This allows testing to determine if the tagged
protein is fully functional and eliminates the presence of
wild-type untagged protein, which would otherwise re-
duce the fraction of complexes incorporating a tagged
protein. The strains are grown at a large scale in liquid
culture before harvesting, lysis, and purification of bio-
tinylated proteins with streptavidin-coated beads. The
bait protein and any bound proteins are then cleaved off
the beads using TEV protease, and analyzed by tandem
mass spectrometry (MS/MS) to determine their
identities.
In vivo biotinylation and purification are highly tissue-
specific
Tissue-specific expression of BirA should result in puri-
fication of the bait protein specifically from that tissue.
However, at least two potential problems might give rise
to biotinylation – and thus purification – of proteins
from unintended tissues. First, if the expression of BirA
is not tightly limited to the tissue of interest, BirA might
be expressed at low levels in other tissues. However,
a
b
Fig. 1 Principles of the approach. a By crossing a transgenic C. elegans strain expressing the Avi-tagged gene of interest (green) with different BirA
driver lines (blue), biotinylation of the tagged protein (red) is accomplished in distinct tissues. b Schematic drawing of the N- and C-terminal tags
designed. Tags contain the sequences encoding GFP (with introns), two Tobacco etch virus (TEV) cleavage sites, and the Avi-tag sequence
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many promoters with well-documented and highly
tissue-specific expression patterns have been identified
in C. elegans. Second, BirA might biotinylate Avi-tagged
proteins after the lysis procedure, when proteins from
the entire animal are mixed together. The risk of this is
low, as BirA activity requires the presence of bivalent
ions, which are chelated by the EDTA in the lysis buffer
[27]. Nevertheless, we first wished to demonstrate the
specificity of biotinylation and purification from a spe-
cific tissue.
To test the tissue specificity of our approach, we gen-
erated transgenic C. elegans strains expressing cytoplas-
mic Avi-tagged GFP from the intestinal elt-2 promoter
and the seam and hyp7 epidermal wrt-2 promoter. Both
GTA strains showed expression of cytoplasmic GFP in
the expected cells (Fig. 3a, b). We crossed each GTA
strain with both epithelial BirA driver strains. Of the
four resulting strains, two expressed the biotin ligase
and GTA in the same tissue (intestine or epidermal
cells), while the other two expressed BirA and GTA in
two different tissues. Animals of all four strains were
lysed, biotinylated proteins were purified using
streptavidin-coated beads, and the presence of GFP was
examined by western blot with an antibody directed
against GFP. All samples showed the expected purifica-
tion pattern: when BirA and GTA were present in the
same tissue, GTA was purified by the streptavidin beads;
when BirA and GTA were expressed in separate tissues,
no GTA was purified (Fig. 3c). Thus, in vivo biotinyl-
ation and protein purification are highly tissue specific.
GTA-tagged bait proteins are functional and recapitulate
known localization patterns
To test the tissue-specific purification approach, we
tagged five polarity regulators that show distinct subcel-
lular localization patterns with the GTA tag: the apical
protein PAR-3, the junctional protein DLG-1, the baso-
lateral proteins LET-413 and LGL-1, and the cortical
protein CDC-42. These five proteins all contain multiple
protein–protein interaction domains and for some of
these proteins, interacting partners have already been
identified in C. elegans or other systems. For example,
DLG-1 interacts with the C. elegans-specific protein
AJM-1, whereas PAR-3 and LGL-1 can both form a
a.
b.
c.
d.
e.
f.
Fig. 2 Schematic of the workflow. a The GTA tag is added to a gene of interest using recombineering. b Transgenic C. elegans strains expressing
the GTA-tagged protein are generated by injection followed by gamma irradiation-mediated integration of the extrachromosomal array. c
Transgenic strains are crossed with strains expressing BirA from a tissue-specific promoter, and with a genetic null mutant if appropriate.
d The transgenic strains are grown in triplicate in liquid culture. e Affinity purification is performed on whole-animal lysates. The bait
protein with any interacting proteins is subsequently cleaved off the beads by Tobacco etch virus (TEV) protease. f The samples are
analyzed by tandem mass spectrometry (MS/MS) to identify the proteins they contain
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complex with PKC-3 and PAR-6, and CDC-42 binds to
PAR-6 [28–33]. For PAR-3, DLG-1, LET-413, and
LGL-1, we added the GTA tag to the C-terminus, as
C-terminal tags are more often compatible with pro-
tein function than N-terminal tags [34]. For CDC-42,
we used the N-terminal tag, as it has already been
shown that C. elegans GFP::CDC-42 is able to localize
to the cortex, similar to wild-type CDC-42 [28]. For
all five genes, we successfully generated integrated
transgenic strains using the procedure outlined in
Fig. 2. We examined the expression pattern of the
tagged bait proteins in the intestine and seam cells
and found that all proteins localized to the expected
subcellular domains (Fig. 4). In both tissues we ob-
served junctional localization of DLG-1::GTA, basolat-
eral localization of LET-413::GTA and LGL-1::GTA,
and cortical localization of GTA::CDC-42. PAR-
3::GTA was visible at the apical surface of the seam
cells. Unexpectedly, no tagged PAR-3 was detected in
the intestinal epithelium. In addition to the epithelial
localization, we also observed expression of DLG-1::GTA
in ventral cord neurons (Fig. 4d), which is consistent with
the expression in neurons of the human homolog DLG4
(PSD-95) [35].
We crossed the dlg-1, lgl-1, and let-413 GTA-tagged
transgenic strains with strains carrying a mutant allele of
the corresponding endogenous gene. cdc-42 and par-3
null alleles are early embryonic lethal [36, 37]. Transgenes
are usually silenced in the germline and are therefore un-
likely to rescue these phenotypes. Consequently, we did
not use mutant backgrounds for these two bait proteins.
The dlg-1::GTA transgenic strain was crossed with a
strain carrying the dlg-1(ok318) deletion allele, which
causes embryonic arrest at the 2-fold stage. Homozygous
dlg-1(ok318) mutants carrying the dlg-1::GTA transgene
were fully viable, demonstrating that the DLG-1::GTA pro-
tein is functional. Loss of lgl-1 does not affect cell polarity
or viability, preventing a complementation test of the
functionality of the lgl-1::GTA transgene [38, 39]. Never-
theless, we crossed our lgl-1::GTA transgenic strain with
the lgl-1(tm2616) deletion allele to prevent incorporation
of untagged LGL-1 protein into complexes. For let-413, no
molecular null allele is available, and the let-413::GTA
transgenic strain was crossed with a strain carrying the let-
413(s128) missense mutation, which causes lethality during
elongation of the developing embryo [40]. While expres-
sion of LET-413::GTA restored embryonic viability, this
strain still grew slowly. LET-413 purifications where there-
fore performed in a let-413 wild-type background.
In summary, the five tagged proteins localize to the
appropriate subcellular domains, and the two transgenes
that we could test in complementation assays rescue the
lethality caused by the corresponding mutant alleles.
Thus, the experimental design appears well suited for
the tagging of proteins of interest, without interfering
with their function.
Large-scale culturing and purification of protein
complexes
Each of the five transgenic strains were crossed with the
Prps-27::BirA (ubiquitous), Pelt-2::BirA (intestine), and
Pwrt-2::BirA (epidermal) BirA driver strains. Because of
the observed neuronal localization of DLG-1, the dlg-
1::GTA strain was also crossed with the pan-neuronal
Prgef-1::BirA transgenic strain (Table 1). As described
above, the dlg-1::GTA and lgl-1::GTA transgenic strains
also carried a putative null mutation in the correspond-
ing endogenous gene. As a negative control to identify
common contaminant proteins or proteins that bind to
the GTA tag, we generated a transgenic strain expressing
cytoplasmic GFP::TEV::Avi from the ubiquitous rps-27
promoter, which was crossed with each of the four BirA
driver strains. In total 20 transgenic strains were gener-
ated for affinity purification: strains expressing one of
the five tagged bait proteins or the GFP::TEV::Avi con-
trol construct, combined with BirA expression from one
a c
b
Fig. 3 In vivo biotinylation is highly tissue-specific. a Expression of GFP::TEV::Avi from the intestinal elt-2 promoter. b Expression of GFP::TEV::Avi
from the seam and hyp7 epidermal cell-specific wrt-2 promoter. In a and b, the tissue and approximate region imaged are indicated in
the cartoon worm. c Western blot detection of GFP::TEV::Avi purified with streptavidin beads from lysates obtained from animals
expressing GFP::TEV::Avi and BirA in the same tissue (lanes 1 and 3) or in different tissues (lanes 2 and 4). Scale bars are 10 μm
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of three different promoters, and in addition, two strains
expressing dlg-1::GTA or GFP::TEV::Avi transgenes com-
bined with BirA expression under the control of the
neuronal rgef-1 promoter.
Each of the 20 strains was grown in large-scale liquid
culture, starting from semi-synchronized L1 cultures
generated by starvation on plates. After growth in liquid
culture, animals were harvested when most larvae were
at the third or fourth larval stage. All strains were grown
and analyzed in triplicate to enhance the possibility of
separating bona fide protein–protein interactions from
nonspecific interactions. All of the harvested cultures
were lysed by sonication, and biotinylated proteins were
purified using streptavidin-coated beads. Next, bait pro-
teins and binding partners were released from the strep-
tavidin beads through TEV protease cleavage.
To examine the specificity of the biotinylation by BirA,
and the efficiency of the purification and subsequent re-
lease by TEV cleavage, we analyzed expression and puri-
fication of DLG-1::GTA (Fig. 5). Western blot analysis of
a
b
c d
Fig. 4 Spinning disc confocal immunofluorescence microscopy images of subcellular localization patterns of GTA-tagged bait proteins. a
Schematic representation of the areas imaged. b Localization in intestinal cells. c Localization in seam cells. In both tissues, CDC-42
localizes to cortex, DLG-1 localizes to cell junctions, and LET-413 and LGL-1 localize to basolateral cortex. PAR-3 localizes apically in seam
cells, while no PAR-3 expression was detected in intestine. d Expression of DLG-1::GTA in ventral cord neurons (e.g., white arrow). Scale
bars are 10 μm
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biotinylated proteins in whole lysates showed a band of
the correct molecular weight in samples expressing
DLG-1::GTA and ubiquitous BirA, which was absent
from the wild-type N2 control (Fig. 5a). No additional
biotinylated bands were detected upon expression of
BirA, indicating that BirA specifically biotinylates the
Avi-tag. Analysis of beads and eluate after purification
with streptavidin beads and TEV cleavage showed that
DLG-1::GFP was released from the beads, while endogen-
ously biotinylated proteins remained bound (Fig. 5b). We
also analyzed the biotinylation efficiency and recovery by
TEV cleavage of GTA::CDC-42. We purified GTA::CDC-
42 from a strain expressing BirA in the seam and hyp7
epidermal cells using GFP-Trap beads as well as streptavi-
din beads (Fig. 5c). The equal levels of recovery (compare
lanes 1 and 2) indicate efficient biotinylation of
GTA::CDC-42. Analysis of beads and eluate after TEV
cleavage of GTA::CDC-42 purified with streptavidin beads
indicate efficient TEV cleavage. However, approximately
half of the CDC-42 remained bound to the beads, despite
having been cleaved by TEV (as indicated by the shift in
apparent molecular weight). Thus, the overall efficiency of
recovery can vary between bait proteins.
Tissue-specific protein purification recovers known LGL-1
interactors
We next analyzed the samples by high-resolution MS. Each
sample was run on a sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) gel for a length of ~1 cm,
followed by in-gel digestion with trypsin and liquid chro-
matography (LC) MS/MS analysis. Raw data are available
via ProteomeXchange with identifier PXD002139. To dis-
tinguish genuine interacting proteins from nonspecific
binding proteins, we analyzed the data using the SAINT
Table 1 Lines generated for purification
BirA driver GTA-tagged bait BirA driver GTA-tagged bait
Prps-27::BirA par-3::GTA
dlg-1::GTA
let-413::GTA
lgl-1::GTA
GTA::cdc-42
Pwrt-2::BirA par-3::GTA
dlg-1::GTA
let-413::GTA
lgl-1::GTA
GTA::cdc-42
Pelt-2::BirA par-3::GTA
dlg-1::GTA
let-413::GTA
lgl-1::GTA
GTA::cdc-42
Prgef-1::BirA dlg-1::GTA
a b
c d
Fig. 5 In vivo biotinylation of GTA-tagged protein and removal of endogenously biotinylated proteins by Tobacco etch virus (TEV) cleavage. a Western
blot detection of biotinylated proteins in lysed wild-type N2 animals (left lane) and lysed animals expressing GTA-tagged DLG-1 and ubiquitously
expressed BirA (right lane). An additional band of the correct estimated molecular weight for DLG-1::GTA is detected upon expression of BirA (arrow).
b Western blot analysis of eluate and beads after purification and release of bound bait protein by TEV cleavage. Both blots contain the same samples.
The background of naturally biotinylated proteins remains bound to the streptavidin beads and is visible on the α-biotin western blot in the beads
remainder, while tagged DLG-1 is cleaved off and visible on the α-GFP western blot in the eluate. No DLG-1 protein is purified in samples from animals
not expressing BirA. c Lanes 1 and 2: Western blot analysis of the levels of GTA::CDC-42 purified with GFP-Trap beads (lane 1) and streptavidin beads
(lane 2) from animals expressing BirA in seam and hyp7 epidermal cells. Lanes 3 and 4: Western blot analysis of beads (lane 3) and eluate (lane 4) after
cleavage of GTA::CDC-42 purified with streptavidin beads. d Schematic of the TEV cleavage procedure
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tool, which was developed to assign confidence scores to
protein–protein interactions identified in AP/MS experi-
ments [41]. Based on label-free quantification data, and
taking into account the number of replicates in which a
protein is observed, as well as negative control data, SAINT
assigns a probability score to each bait–prey pair identified
[41]. Scores range from 0 to 1, and interactions scoring
>0.8 can be considered to represent high confidence inter-
actions [41]. We analyzed our samples using SAINT
Express embedded within the CRAPome online interface
[42]. Spectral counts for the triplicate experiments and
negative control samples were uploaded and processed
using the default settings. The four tissues analyzed (ubiqui-
tous, epidermal, intestine, neuronal) were processed separ-
ately. The results are presented in Additional file 4: Table
S1 and Additional file 5: Table S2.
The bait proteins LGL-1, CDC-42, DLG-1, and LET-
413 were each themselves identified with high confi-
dence: SAINT probability scores were ≥0.98 in all tissues
examined, with the exception of LET-413 in the intestine
(score of 0.86). Bait protein PAR-3 was only identified in
the ubiquitous sample, with a SAINT score of 0.65. Be-
cause PAR-3::GTA was readily detected by microscopy,
the protein is likely not efficiently recovered in our puri-
fication procedure. PAR-3 samples were therefore ex-
cluded from further analysis. The remaining four baits
together identified 55 high confidence interactions,
which were identified in at least one tissue with a
SAINT score >0.8. However, 24 of these were ribosomal
proteins or proteins associated with ribosome biogenesis,
and most of these were identified with multiple bait pro-
teins (22/24 were found by all four baits). Disregarding in-
teractions with these ribosome-associated proteins, we
identified 25 interactions with DLG-1, two interactions
with LET-413, and three interactions with LGL-1 (Table 2
and Additional file 6: Table S3). No interactions with a
SAINT score >0.8 were identified with CDC-42. However,
in an independent experiment, CDC-42 co-purified with
the RhoGDI RHI-1, a known interactor of CDC-42 [43]
(not shown), which indicates that adjusting purification
conditions may yield additional interacting proteins.
The proteins that co-purified with LET-413 appear
unlikely to be specifically involved in cell polarity:
B0303.3 is a homolog of β-ketothiolase, and QARS-1
is a glutaminyl tRNA synthetase. In contrast, LGL-1
co-purified with PAR-6 and PKC-3. C. elegans LGL-1
was previously found to be associated with PAR-6
and PKC-3 in embryos [39], and Drosophila and
mammalian Lgl form a complex with Par-6 and aPKC
[29, 32, 33]. In our experiments, PAR-6 and PKC-3 both
co-purified with LGL-1 biotinylated specifically in the
intestine or seam and hyp7 epidermal cells, as well as with
ubiquitously biotinylated LGL-1. These results demon-
strate that our biotinylation-based approach is able to
identify biologically relevant interactions from specific tis-
sues with high confidence.
Identification of a novel interaction between DLG-1 and
the AAA ATPase-family protein ATAD-3
To validate the ability of our approach to identify novel
interactors, we focused on the candidate DLG-1 interaction
partner ATAD-3, which was identified with high confidence
using ubiquitously biotinylated DLG-1::GTA, as well as
with lower confidence using BirA expressed in epidermal
cells, intestine, and neurons (Table 2). Moreover, ATAD-3
was not identified with any confidence with the other bait
proteins (Additional file 5: Table S2). ATAD-3 is an evolu-
tionarily conserved AAA-family ATPase that is essential for
mitochondrial activity and development of C. elegans [44].
We verified the ubiquitous nature of the DLG-1/ATAD-3
interaction by immunoprecipitating ATAD-3 and DLG-1
from embryonic lysates using specific antibodies. Purifica-
tion of ATAD-3 revealed co-immunoprecipitation of DLG-
1 at a level that was comparable to that observed after
DLG-1 immunoprecipitation (Fig. 6a, compare lane 7 and
4). This suggests that a major fraction of DLG-1 interacts
with ATAD-3 in the embryo. Conversely, purification of
DLG-1 resulted in the co-immunoprecipitation of only a
small amount of ATAD-3 (Fig. 6a, lane 4). Purification of
ATAD-3 or DLG-1 from lysates of embryos treated with
RNAi directed against dlg-1 or atad-3 failed to co-
immunoprecipitate substantial amounts of DLG-1 or
ATAD-3. Thus, the co-immunoprecipitation of DLG-1 is
dependent on the presence of ATAD-3, and vice versa. To-
gether, these data indicate that DLG-1 specifically interacts
with ATAD-3.
DLG-1 contains three PDZ domains, which are known to
function as protein interaction modules. Yeast two-hybrid
experiments with fragments of DLG-1 revealed that
ATAD-3 binds to the second PDZ domain of DLG-1
(Fig. 6b). PDZ domains frequently bind to short C-terminal
motifs in interacting proteins, and the final four amino
acids of ATAD-3 (ETAV) match a predicted PDZ domain-
binding-specificity class [45]. Indeed, removal of the ETAV
sequence rendered ATAD-3 incapable of binding to DLG-1
in the yeast two-hybrid system (Fig. 6b). This indicates that
ATAD-3 binds with its C-terminal ETAV motif to the sec-
ond PDZ domain of DLG-1. To investigate whether the
ETAV motif is necessary in vivo to mediate the interaction
of ATAD-3 with DLG-1, we generated strains expressing
full-length ATAD-3 (ATAD-3FL), or ATAD-3 lacking the
C-terminal four amino acids (ATADΔETAV). We inserted
single-copy transgenes in chromosome IV by MosSCI [46],
and crossed these animals with the atad-3(ok3093) strain to
obtain animals expressing only the transgene. Both strains
express ATAD-3 at levels comparable to wild type (Fig. 6c
and Additional file 7: Figure S4). Co-immunoprecipitation
experiments showed that ATADFL interacts with DLG-1 in
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embryos (Fig. 6c). In contrast, truncation of the C-terminal
ETAV motif of ATAD-3 completely prevented the DLG-1
interaction in vivo (Fig. 6c). These data strongly support
the presence of a direct physical interaction between
ATAD-3 and DLG-1, mediated by the second PDZ domain
of DLG-1 and the C-terminal ETAV motif of ATAD-3.
Both the ATAD-3FL and the ATADΔETAV strains are vi-
able. However, ATADΔETAV animals displayed a dramatic-
ally reduced fertility compared to wild type, as well as an
increase in embryonic lethality (Fig. 6d). This phenotype
was exacerbated at 25 °C compared to 15 °C. These findings
indicate that the interaction between ATAD-3 and DLG-1
is physiologically relevant.
Identification of a C. elegans MAP1-family member as a
candidate neuron-specific DLG-1 interacting protein
Four of the DLG-1 interactors co-purified exclusively with
DLG-1::GTA biotinylated in neurons, and may therefore
Table 2 Candidate interactors identified
Bait Interactor SAINT confidence scores Description
Ubiquitous Intestine Seam/hyp7 Neuron
CDC-42 CDC-42 1.00 1.00 1.00 - RHO GTPase
DLG-1 VIT-5 0.60 0.00 1.00 0.33 Vitellogenin
DLG-1 UNC-87 1.00 0.54 0.36 0.61 Maintains structure of myofilaments
DLG-1 DLG-1 1.00 1.00 1.00 1.00 Discs large
DLG-1 VIT-6 0.65 0.00 0.99 0.33 Vitellogenin
DLG-1 ATAD-3 0.99 0.46 0.71 0.49 Mitochondrial protein ATAD3
DLG-1 DIM-1 0.22 0.00 0.04 0.98 Uncharacterized
DLG-1 C39H7.4 0.65 - 0.98 0.33 Uncharacterized
DLG-1 COR-1 0.97 0.33 0.33 0.33 Coronin
DLG-1 LEC-1 0.96 0.06 0.84 0.62 Tandem-repeat type galectin
DLG-1 MAPH-1.1 0.00 - - 0.93 MAP1 homolog
DLG-1 IFB-2 0.66 0.00 0.90 0.93 Intermediate filament protein
DLG-1 F49H12.5 0.56 0.03 0.01 0.93 Thioredoxin domain containing 12
DLG-1 LARP-1 0.00 0.00 0.21 0.92 La-related protein
DLG-1 IFC-2 0.00 0.00 0.91 0.33 Intermediate filament protein
DLG-1 LEC-2 0.90 0.00 0.91 - Tandem-repeat type galectin
DLG-1 R09H10.5 0.89 0.25 0.91 0.32 Uncharacterized
DLG-1 MUP-2 0.90 0.63 0.28 0.66 Muscle contractile protein troponin T
DLG-1 ATN-1 - 0.31 0.90 - Alpha-actinin homolog
DLG-1 GPD-2 0.83 0.01 0.89 0.39 GAPDH
DLG-1 QARS-1 0.00 0.00 0.88 0.39 Glutaminyl (Q) tRNA synthetase
DLG-1 VARS-2 0.00 - 0.00 0.88 Valyl-tRNA synthetase
DLG-1 NMT-1 0.00 - 0.58 0.87 N-myristoyl transferase
DLG-1 MRG-1 0.00 0.00 0.12 0.87 Homolog of MRG15
DLG-1 EPS-8 0.85 0.05 0.82 0.66 Cell signaling adaptor protein
DLG-1 T25F10.6 0.83 0.64 0.22 0.33 Calponin
DLG-1 LEC-4 0.65 - 0.81 0.33 Tandem-repeat type galectin
LET-413 LET-413 1.00 0.86 1.00 - Scribble
LET-413 B0303.3 0.82 0.00 - - Beta-ketothiolase
LET-413 QARS-1 0.82 0.01 - - Glutaminyl (Q) tRNA synthetase
LGL-1 LGL-1 1.00 1.00 1.00 - Lethal giant larvae (Lgl)
LGL-1 PAR-6 0.99 1.00 0.98 - Par-6
LGL-1 PKC-3 0.98 0.97 0.91 - Atypical protein kinase C
LGL-1 QARS-1 0.82 0.00 0.00 - Glutaminyl (Q) tRNA synthetase
Shown are putative interactors identified with a SAINT confidence score >0.8 in at least one of the four tissues examined. Ribosomal proteins are not shown. An
expanded copy of this table including spectra counts is shown in Additional file 5: Table S2
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represent proteins that function with DLG-1 specifically in
this tissue. BLAST searches with one of these proteins,
F32A7.5, identified the MAP1 family of microtubule-
associated proteins (MAPs) as the closest homologs of
F32A7.5. Mammalian genomes generally encode three
MAP1 proteins: MAP1A, MAP1B, and the shorter family
member MAP1S. In Drosophila, a single homolog termed
Futsch has been described, which shares homology with
mammalian MAP1A and MAP1B in the N- and C-terminal
regions [47]. Interestingly, MAP1A localizes to postsynaptic
densities, and interacts with the DLG-1 homologs DLG1
(SAP-97), DLG2 (PSD-93), and DLG4 (PSD-95) [48, 49]. To
date, no C. elegans MAP1-family proteins have been de-
scribed. We hypothesized that F32A7.5 represents a C. ele-
gans MAP1-family member, and examined this protein in
more detail.
MAP1A, MAP1B, and Futsch are large proteins (pre-
dicted molecular weights 305 kDa, 270 kDa, and 592 kDa,
respectively) with no predicted folded domains and
extensive predicted unstructured regions. All three pro-
teins are proteolytically cleaved into a heavy chain and a
26–30 kDa light chain derived from the C-terminus [50].
C. elegans F32A7.5 is smaller (predicted molecular weight
before cleavage 92 kDa), but also contains a large pre-
dicted unstructured region. Analogous to Futsch, the simi-
larity of F32A7.5 with the mammalian MAP1 proteins
was largely limited to the N- and C-terminus (Fig. 7a).
Phylogenetic analysis indicated that F32A7.5 is equally re-
lated to MAP1A, MAP1B, and MAP1S (Fig. 7b and Add-
itional file 8: Figure S5). The C. elegans genome encodes
two other proteins that are highly similar to F32A7.5,
termed F25D7.4 and C36A4.5. The high degree of similar-
ity between these proteins (>85 % amino acid identity)
indicates that they are paralogs, and in the EggNOG 4.1
database of orthologous groups all three proteins are
placed in the same orthologous group as mammalian
MAP1A, MAP1B, and MAP1S [51]. Based on phylogeny
and the results presented below, we name these proteins
a
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Fig. 6 Confirmation of the DLG-1/ATAD-3 interaction and mapping of the interaction domain. a Western blots showing co-immunoprecipitation
(IP) of DGL-1 and ATAD-3. To demonstrate specificity of the detection, samples were treated with control RNAi (GFP RNAi) or RNAi against dlg-1
or atad-3. Left panels: input lysates before IP. Middle panels: DLG-1 IP. Right panels: ATAD-3 IP. b ATAD-3 interacts with DLG-1 in yeast two-hybrid
experiments. This interaction depends on the C-terminal ETAV motif of ATAD-3 and the second PDZ domain of DLG-1. Note that ATAD-3
fragments lacking this C-terminal ETAV motif fail to interact with DLG-1 PDZ domains. A fragment containing PDZ 1–3 domains from
Drosophila Bazooka was used as a negative control. n.d. not determined. c IP/western blotting experiment shows that, in vivo, the DLG-1/
ATAD-3 interaction requires the C-terminal ETAV motif of ATAD-3. Lanes on the left show input signals of DLG-1 and ATAD-3. The lanes
on the right show IPs in corresponding lysates. d Progeny produced by N2 animals, or animals expressing full-length ATAD-3 (ATAD-3FL)
and ATAD-3 lacking the C-terminal four amino acids (ATADΔETAV) at 15 °C and 25 °C. Total: average total progeny produced. Emb: average
number of embryonic lethal progeny produced. Bars represent average values, and error bars the standard deviation. n = 4
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Fig. 7 (See legend on next page.)
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MAPH-1.1, MAPH-1.2, and MAPH-1.3, for “micro-
tubule-associated protein 1 homolog 1.”
To examine the expression pattern and subcellular
localization of MAPH-1.1, and to validate the interaction
with DLG-1, we used CRISPR/Cas9-based genome
editing to engineer a GFP-tagged maph-1 locus
(GFP::maph-1.1). By western blot, GFP::MAPH-1.1 has
an apparent molecular weight of ~60 kDa, much lower
than the predicted 119 kDa molecular weight of an un-
processed GFP::MAPH-1.1 fusion (Fig. 7c lane 2). This
indicates that, like the mammalian Map1 proteins,
MAPH-1.1 is proteolytically cleaved. To confirm the co-
affinity purification of MAPH-1.1 with DLG-1, we
crossed the GFP::maph-1.1 strain with a strain express-
ing DLG-1::GTA from its own promoter and BirA from
the neuronal rgef-1 promoter. As a control, we crossed
the GFP::maph-1.1 strain with a strain ubiquitously ex-
pressing cytoplasmic GFP::TEV::Avi, and expressing
BirA in neurons. We purified DLG-1::GTA using
streptavidin-coated beads, and tested for co-purification
of MAPH-1.1 by western blotting using an antibody de-
tecting GFP. We observed co-purification of MAPH-1.1
with DLG-1::GTA, but not with the GFP::TEV::Avi con-
trol (Fig. 7c). This confirms the identification of MAPH-
1.1 in neuronal DLG-1 purifications by MS.
We observed broad expression of GFP::MAPH-1.1 in
multiple somatic postembryonic tissues. This included
neurons, but also body wall muscle cells, the vulva, vul-
val muscle cells, the hypodermis, seam cells, and intes-
tinal cells (Fig. 7d). The fact that we did not identify
MAPH-1.1 in DLG-1 purifications from seam or intes-
tinal cells implies that this interaction is either occurring
only in neurons, or stabilized in neurons by a neuron-
specific protein.
The subcellular localization pattern of GFP::MAPH-1.1
closely resembled that of previously described non-
centrosomal microtubule arrays in uterine muscle cells
[52], circumferential microtubule arrays in the hypodermis
[53], and body wall muscle cells [54] (Fig. 7d). Further-
more, live imaging revealed a highly dynamic behavior of
the observed arrays, including shrinkage events
(Additional file 9: Movie S1; Additional file 10: Movie S2;
Additional file 11: Movie S3; Additional file 12: Movie S4;
Additional file 13: Movie S5; and Additional file 14: Movie
S6). We measured the shrinkage rate of several arrays in
the hypodermis and body wall muscle cells, and obtained
an average rate of 0.76 μm/s and 0.85 ± 0.14 μm/s respect-
ively (Additional file 15: Figure S6). These rates are con-
sistent with the previously observed shrinkage rate of
0.85 μm/s for non-centrosomal microtubule bundles in
differentiated uterine muscle cells [52]. Finally, we exam-
ined the dynamics of GFP::MAPH-1.1 using fluorescence
recovery after photobleaching (FRAP). GFP::MAPH-1.1
showed a half-time of recovery of 6 s, which is similar to
the rapid dynamics observed for the microtubule-binding
domain of ensconsin (MAP7) [55]. All of these observa-
tions are consistent with MAPH-1.1 acting as a microtubule-
binding protein. Nevertheless, in body wall muscle cells and
the hypodermids, tubulin and actin can form bundles that
are similar in appearance. Given that mammalian MAP1
proteins can associate with actin [50], we cannot exclude
that MAPH-1.1 also localizes to actin structures.
To further confirm the localization of MAPH-1.1 to
microtubules, particularly in neurons, we expressed a
translational GFP::MAPH-1.1 fusion protein in cultured
primary rat hippocampal neurons, in which microtu-
bules are easily visualized. Co-staining with an antibody
directed against α-tubulin showed clear co-localization
of MAPH-1.1 with microtubules in the neuronal cell
body, axon, and dendrites (Fig. 7e). We also expressed a
DLG-1:: mCherry fusion protein in cultured hippocam-
pal neurons, and observed localization to synaptic
structures in dendrites (Fig. 7f ). We conclude that, like
mammalian MAP1A, MAPH-1.1 is a microtubule-
associated protein, and a candidate neuron-specific
interaction partner of DLG-1. In contrast to MAP1A,
(See figure on previous page.)
Fig. 7 MAPH-1.1 is a microtubule-associated protein related to mammalian MAP1 proteins. a Sequence similarity between MAPH-1.1 and
human MAP1A, and between MAPH-1.1 and Drosophila Futsch. For each protein the predicted disordered region is indicated in green.
Protein sizes are to scale. For MAP1A and Futsch, a red line indicates the proteolytic cleavage site that is used to generate a light chain
(LC2 and LCf). A dotted red line indicates the homologous position in MAPH-1.1. Sequence similarity is indicated for three regions: two
conserved N- and C-terminal regions (indicated in gray) and the intervening less conserved region. Amino acid coordinates for these
regions are: MAP-1 N-terminal region 274–544, MAP-1 C-terminal region 2847–3041, MAPH-1.1 N-terminal region 1–230, MAPH-1.1 C-
terminal region 742–878, Futsch N-terminal region 291–956, and Futsch C-terminal region 5082–5495. b Phylogenetic tree of MAP1-related
proteins. Color coding indicates groups containing human MAP1A (green), MAP1B (red), and MAP1S (blue). cWestern blots showing co-immunoprecipitation of
DGL-1::GTA and GFP::MAPH-1.1. Input lysates (150 μg protein, lanes 1–4) show expression of DLG-1::GTA (arrowheads), GFP::MAPH-1 (arrow), and the
empty GTA tag (asterisk). MAPH-1.1 co-purifies with DLG-1::GTA (lane 6) but not with the GTA tag alone (lane 5). Strains used are N2 (lane 1), BOX188
(lane 2), BOX209 (lanes 3 and 5), BOX212 (lanes 4 and 6). d Expression of GFP::MAPH-1 from an endogenously tagged GFP::maph-1.1 locus. Nerve ring,
pharynx, seam cells, and hypodermis panels were taken from the same L4 stage animal. Body wall muscle and vulva panels are ventral views from a
second animal. Arrowheads indicate the nerve ring an two seam cells. Cartoons are schematic representations of the areas imaged. e Expression of an
N-terminal GFP::MAPH-1.1 fusion in 6-day-old primary rat hippocampal neuron cultures. Cells were co-stained for MAP2, which localizes to microtubules
in dendrites, and for α-tubulin. The right panel is a merge with MAP2 in cyan, MAPH-1.1 in green, and microtubules in magenta. The arrowhead indicates the
axon. f Expression of a C-terminal DLG-1::mCherry fusion in 24-day-old primary hippocampal neuron cultures. All scale bars are 10 μm
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however, maph-1.1 is broadly, if not ubiquitously,
expressed.
Discussion
Here, we describe an in vivo biotinylation-based AP/MS
approach to purify protein complexes from specific tis-
sues in C. elegans. Proteins of interest were expressed
with a GTA tag under the control of their normal regu-
latory sequences, and biotinylation in a single tissue was
accomplished by expressing BirA from a tissue-specific
promoter. Expression of GFP::TEV::Avi and BirA in two
different tissues confirmed that biotinylation and purifi-
cation are indeed tissue-specific. The ability of our ap-
proach to identify bona fide protein interactions from
specific tissues was demonstrated by the identification of
the known LGL-1 interaction partners PAR-6 and PKC-
3 from two distinct epithelial tissues. We also detected a
prominent interaction between the junctional scaffold
protein DLG-1 and the mitochondrial AAA ATPase
ATAD-3. We confirmed this interaction through affinity
purification, identified the interacting motif by yeast
two-hybrid assays, and demonstrate the requirement for
this motif for the ATAD-3/DLG-1 interaction in vivo. Fi-
nally, through neuron-specific purification of DLG-1 we
identified MAPH-1.1 as an interactor of DLG-1, and
demonstrate that this protein represents a C. elegans
member of the MAP1 family of MAPs.
As is generally the case with interaction detection as-
says, not all known interactions were recovered. In some
cases, this may have been due to the stringency of the
SAINT threshold of 0.8, as potentially relevant interac-
tions were observed below this threshold. For example,
AJM-1 is a known interaction partner of DLG-1 [31],
and co-purified with DLG-1 from neurons with a SAINT
score of 0.33. Similarly, in MDCK cells, Scribble has
been reported to associate with Lgl2 [56], and in our ex-
periments LGL-1 co-purified with LET-413 from intes-
tine with a SAINT score of 0.33. Neither AJM-1 nor
LGL-1 co-purified with other baits, which indicates that
these may represent valid and specific interactions. We
also observed that not all bait proteins were recovered at
equal levels, which may contribute to the lack of recov-
ery of some known interaction partners. A number of
different reasons may cause inefficient bait protein re-
covery. For example, some proteins may be present at
low levels, or may not be effectively released in soluble
form into the supernatant by the lysis procedure. It is
also possible that some proteins are biotinylated less effi-
ciently in vivo, or that the efficiency of TEV cleavage
varies. In part, such issues may be overcome by
optimization of lysis and purification conditions for spe-
cific bait proteins.
An affinity purification tag incorporating GFP and Avi
has been used previously in C. elegans to purify a protein
complex [19]. However, tissue specificity of the biotinyl-
ation and purification procedure had not been demon-
strated, and no tissue-specific protein interactions had
been identified to date. Two other proteomics ap-
proaches using BirA-mediated in vivo biotinylation have
also been described in C. elegans. One study used in vivo
biotinylation of the histone H3.3 protein for the purifica-
tion of chromatin and epigenetic profiling [57]. Another
study used biotinylation of the nuclear pore complex
component NPP-9 to purify nuclei from specific tissues
[58]. Thus, in vivo biotinylation is proving to be a versa-
tile method for tissue-specific proteomics approaches in
C. elegans.
The GTA tag includes GFP to visualize the subcellular
localization of tagged proteins. The expression patterns
of the GTA-tagged proteins we observed largely con-
firmed known localizations, though we failed to observe
intestinal localization of PAR-3::GTA. Possibly, the regu-
latory sequences of PAR-3 extend beyond the region in-
cluded in the fosmid, or the par-3 splice variants we
tagged are not expressed in the intestine. Two alterna-
tive start sites have already been documented to affect
the expression pattern of par-3, and it is conceivable
that different 3′-ends can also affect par-3 expression
[59]. In addition to previously described localization pat-
terns, we observed expression of DLG-1::GTA in ventral
cord neurons. Although the localization did not clearly
resemble a synaptic pattern, this observation is consist-
ent with the identification of mammalian DLG-1 homo-
logs as postsynaptic density (PSD) proteins.
We identified a novel interaction between the junctional
scaffold protein DLG-1 and the evolutionarily conserved
mitochondrial AAA ATPase ATAD-3. ATAD-3 and its ho-
mologs in other species (ATAD3A, ATAD3B) have been
described as mitochondrial proteins with roles in tumor
progression [44, 60–63]. Inactivation of atad-3 by RNAi
causes defects in the development and functioning of mito-
chondria, and results in embryonic lethality and early larval
arrest [44]. Immunopurification followed by western blot-
ting indicated that a substantial fraction of DLG-1 associ-
ates with ATAD-3, while only a small sub-fraction of
ATAD-3 is in complex with DLG-1. ATAD-3 contains a
putative transmembrane domain and has been reported to
be inserted into the inner membrane of mitochondria, with
its C-terminus located in the matrix and the N-terminus
facing the cytosol [61, 64, 65]. Given the specific binding of
DLG-1 to the C-terminal end of ATAD-3, the DLG-1/
ATAD-3 interaction should either occur in the matrix of
mitochondria, or involve a subpopulation of ATAD-3 that
is not present in the mitochondria. Results from several
studies support that mammalian ATAD3A does not reside
exclusively in mitochondria [60, 66, 67]. In fact, a substan-
tial number of mitochondrial proteins are dually localized
[68]. In particular, proteins that have a less well-defined
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mitochondrial targeting sequence are more likely to be
found at multiple subcellular locations. ATAD-3 has no
recognizable mitochondrial targeting sequence and has
been found in the plasma-membrane in certain cancer cells
[67], and in the endoplasmic reticulum mitochondria-
associated membrane (MAM) fraction [60]. These findings
indicate the possibility for interactions with ATAD-3 out-
side of mitochondria. Our finding that expression of
ATAD-3FL rescues the atad-3(ok3093) mutation to a
greater extent than expression of ATADΔETAV suggests that
the DLG-1/ATAD-3 interaction plays an important role in
C. elegans development. In epithelial cells, DLG-1 localizes
to cell junctions [69], a location that has not been observed
for ATAD-3. Although the exact contribution of the inter-
action with ATAD-3 to DLG-1 remains to be discovered, it
is possible that this interaction is of importance before the
formation of cell junctions, or affects a non-junctional pool
of DLG-1.
MAPs control the organization, stability, and function
of the microtubule cytoskeleton [50]. The mammalian
MAP1 family of MAPs contains three family members:
MAP1A, MAP1B, and the smaller MAP1S [50]. In Dros-
ophila, a single MAP1 protein, termed Futsch, has been
identified [47]. MAP1A, MAP1B, and Drosophila Futsch
are predominantly expressed in neurons, and have been
shown to play a role in several aspects of neuronal de-
velopment and functioning [47, 50]. MAP-1A is found
in PSDs, where it interacts with the mammalian DLG1
(SAP-97), DLG2 (PSD-93), and DLG4 (PSD-95) [48, 49].
To date, no C. elegans MAP1 proteins had been de-
scribed, and no clear orthologs are present in the gen-
ome. Purification of C. elegans DLG-1 from neurons
resulted in the identification of F32A7.5 as a candidate
interaction partner. Based on sequence similarity to
mammalian MAP1 proteins, we postulate that F32A7.5
is a C. elegans MAP1 protein, which we named MAPH-
1.1 for “microtubule-associated protein 1 homolog 1.”
MAPH-1.1 did not co-purify with DLG-1 biotinylated in
the intestine or epidermal cells, nor with ubiquitously bi-
otinylated DLG-1, despite expression of MAPH-1.1 in
many non-neuronal tissues, including seam and intes-
tine. Despite the high SAINT score with which MAPH-
1.1 was identified in neuron-specific DLG-1 purifications,
the actual number of peptides identified was low. This
may reflect that only a minor fraction of DLG-1 and
MAPH-1.1 associate in neurons, or that a neuron-specific
protein stabilizes the DLG-1/MAPH-1.1 interaction,
which would illustrate the value of using a tissue-specific
approach. However, further study will be needed to con-
firm a biological role of this interaction in neurons in vivo.
The localization of MAPH-1.1 to dynamic arrays re-
sembling previously published microtubule arrays, the
shrinkage parameters of these arrays, and the co-
localization with microtubules in cultured rat primary
hippocampal neurons all support a function for MAPH-
1.1 as a MAP. The C. elegans genome encodes two other
proteins that are highly similar to F32A7.5, termed
F25D7.4, and C36A4.5, which we termed MAPH-1.2
and MAPH-1.3. We did not identify MAPH-1.2 in any
of our purifications, but MAPH-1.3 also interacted with
DLG-1 specifically in neurons, though at a much lower
confidence level (SAINT score 0.33).
MAP1A binds to the guanylate kinase (GK) domain of
DLG4 through a short peptide motif [49], which does
not appear to be conserved in the C. elegans MAPH-1
proteins. However, mutational analysis of the GK bind-
ing motif showed that it is highly permissive of changes,
and GK binding sites do not appear to be well conserved
across different proteins [49]. Thus, it is possible that
the mammalian consensus sequence has diverged from
the MAPH-1.1 binding site for DLG-1. Mammalian
MAP1A and MAP1B, as well as Futsch, are proteolytic-
ally cleaved into heavy and light chains [50, 70]. Residues
surrounding the cleavage site are poorly conserved be-
tween MAP1A/B and Futsch, and we could not identify
a candidate cleavage site in MAPH-1.1 by sequence ana-
lysis. Thus, it remains to be determined if the C. elegans
MAPH-1 proteins are proteolytically cleaved. In mam-
mals, MAP1A and MAP1B heavy and light chains as-
semble into a trimeric complex together with the
separately encoded MAP1 light chain 3 (LC3) [50]. The
C. elegans protein LGG-2, which plays an important role
in the generation of autolysosomes, is highly similar to
LC3 [71], consistent with conservation of the mechan-
ism of MAP1 functioning in C. elegans. However, a role
for LGG-2 in neuronal function or microtubule regula-
tion has not been examined.
Conclusions
The approach we presented here should be widely
applicable for the identification of protein complexes
for many proteins, provided that the bait protein is
soluble after lysis and can be tagged at either the N-
terminus or C-terminus without interfering with the
function of the protein. In addition, our approach can
be used to identify tissue-specific protein modifica-
tions of the bait protein, such as phosphorylations,
and to reveal differences in protein complex compos-
ition over time by using synchronized cultures. Here,
we used fosmid-based recombineering to generate the
transgenic strains. With the development of CRISPR/
Cas9-based genome engineering, it has become pos-
sible to endogenously tag any C. elegans gene of
interest [72]. Thus, genes can now be endogenously
tagged with the GTA tag, which eliminates the need
for crosses with a null mutant background, and
should result in even more reliable expression
patterns.
Waaijers et al. BMC Biology  (2016) 14:66 Page 14 of 24
Methods
Cloning of GTA tags
To generate the N- and C-terminal GTA tag constructs
pMB41 and pMB72, we inserted TEV and Avi sequences
obtained as synthetic DNA constructs from GenScript
(http://www.genscript.com), and codon-optimized GFP/
GalK sequences from vector pBALU1 [26] into vector
pUC19 (NEB, http://www.neb.com) by Gibson assembly.
Vector maps and sequences are available in Additional
file 16. pMB41 and pMB72 are available through
Addgene (see “Availability of data and materials” below).
Recombineering
The recombineering approach we used has been de-
scribed previously [26]. Briefly, the fosmid to be engi-
neered is transformed into E. coli strain SW105, a galK-
defective strain carrying a heat shock-inducible phage λ
Red recombinase, and an arabinose-inducible Flp recom-
binase. Bacteria carrying the fosmid are transformed
with a PCR product consisting of the tag to be intro-
duced, which also carries the wild-type galK sequence,
flanked on both sides by 50 nucleotides identical to the
insertion site. Expression of λ Red induces homologous
recombination between the fosmid and the PCR product,
and successful recombinants are selected on media with
galactose as the only carbon source. Finally, galK se-
quences, which are flanked by FRT sites, are eliminated
from the fosmid by expression of the Flp recombinase.
We used the following fosmids and primers to generate
the PCR products used as templates for homologous re-
combination: For tagging dlg-1 we used the C-terminal tag,
fosmid WRM067dB05, and primers rec_dlg-1_C-term_F
(5′-actccatcatcagccgtgaatcgcagacgccaatttgggtgccacgtcatgga
ggaggatctggaggaggaggatctggaggagga) and rec_dlg-1_C-te
rm_R (5′-acatatttcttgaagaaacgattatttgtctaaaaaatatccaatttcat
ctattcatgccattcaatcttctgagcttcg); for let-413 the C-terminal
tag, fosmid WRM0640dF02, and primers rec_let-413_C-
term_F (5′-ggtccccatcgccagtttcgagaacatctgtgagtaggccatgtg
agtatggaggaggatctggaggaggaggatctggaggagga) and rec_let-
413_C-term_R (5′-gaatgtcaaaaaaaaaacgtctaatgtctagttttcagc
caaaatcggcctcattcatgccattcaatcttctgagcttcg); for lgl-1 the C-
terminal tag, fosmid WRM065bB11, and primers rec_lgl-
1_C-term_F (5′-gaagtacggtgaatttgaactttcgcggttggagcagtacg
cacaagtcaggaggaggatctggaggaggaggatctggaggagga) and rec
_lgl-1_C-term_R (5′-aaaattaatatatatcaacaggaaaacgatttttaa
aaaaaatgcatctattcatgccattcaatcttctgagcttcg); for par-3 the C-
terminal tag, fosmid WRM064bG02, and primers rec_par-
3_C-term_F (5′-gccaataccgtcgcagagatcagggaccgcctcatcgtt
ttccccagtacggaggaggatctggaggaggaggatctggaggagga) and
rec_par-3_C-term_R (5′-gattccgtatttttcgcggctgcgtaatataac
tttgagaaaaaactgacctattcatgccattcaatcttctgagcttcg); and for
cdc-42 the N-terminal tag, fosmid WRM0612bG08, and
primers rec_cdc-42_N-term_F (5′-ctataaagacgtaattttaat
acttttattcattttttttttcaggcgaaaaaaatgggacttaatgatattttcgaagctc
ag) and rec_cdc-42_N-term_R (5′-gttttaccgacagctccatctc
caacgacgacgcacttgatcgtctgcatacctcctcctccagatcctcctcct). To
check whether the recombineering procedure was success-
ful we performed a PCR reaction on the constructs with
primers rec_dlg-1_C-term_check_F (5′-aagctcaagcgcagt
attcc) and rec_dlg-1_C-term_check_R (5′-tttcttgaattgagaa
cttggaaa) for dlg-1, primers rec_let-413_C-term_check_F
(5′-cgattggtattccgattggt) and rec_let-413_C-term_check_R
(5′-gccgaacagtaacggagatt) for let-413, primers rec_lgl-1_C-
term_check_F (5′-gggagttatgtacaggcatctagta) and rec_lgl-
1_C-term_check_R (5′-taagccagccgctagcac) for lgl-1,
primers rec_par-3_C-term_check_F (5′-tatgccgcgaaggagaa
gta) and rec_par-3_C-term_check_R (5′-ttcgctcagcggaatt
atc) for par-3, and primers rec_cdc-42_N-term_check_F
(5′-tcgtttattaaggcgtttaccg) and rec_cdc-42_N-term_check
_R (5′-cgatcgtaatcttcctgtcc) for cdc-42.
Cloning the BirA constructs
The C. elegans codon-optimized BirA sequence was ob-
tained as a synthetic DNA construct from GenScript
(http://www.genscript.com). To generate the BirA expres-
sion constructs pMB37 (Prps-27::BirA), pMB71 (Pelt-
2::BirA), and pMB73 (Pwrt-2::BirA), the BirA sequence
was cloned into vector pPD158.87 (Addgene #1709) using
KpnI and EcoRI restriction sites. For vector pBT331
(Prgef-1∷BirA), the BirA sequence was cloned into vector
backbone pPD95.77 (Addgene plasmid #1495) using KpnI
and EcoRI. Next, promoter regions were amplified from
C. elegans genomic DNA and cloned into appropriate
restriction sites. For pMB37, the rps-27 promoter was
amplified using primers Prps-27F (5′-aaa CTGCAGtt-
caatcggtttttccttgcttgc) and Prps-27R (5′-aaaGGTACCattcc
acttgttgagcggggctg), and cloned using PstI/KpnI. For
pMB71, the elt-2 promoter was amplified using primers
Pelt-2F (5′-aaaCTGCAGtaatttcgaaatgtatgaactccaattc) and
Pelt-2R (5′-aaaCCCGGGctataatctattttctagtttc), and cloned
using PstI/SmaI. For pMB73, the wrt-2 promoter was
amplified using primers Pwrt-2F (5′-aaaCTGCAGcaggtcg
actccacgtaatttc) and Pwrt-2R (5′-aaaCCCGGGGATCCccg
agaaacaattggcaggttg), and cloned using PstI/SmaI. For
pBT331, the rgef-1 promoter was amplified using primers
Prgef-1F (5′- aaaCTGCAGcgtttccgatacccccttatatc) and
Prgef-1R (5′-aaaCCCGGGgatcctttactgctgatcgtcg), and
cloned using PstI/SmaI. Vector maps and sequences are
available in Additional file 16. The BirA expression con-
structs are available through Addgene (see “Availability of
data and materials” below).
Cloning the control constructs
To generate expression constructs pMB43 (Prps-
27::GTA), pMB76 (Pelt-2::GTA), and pMB77 (Pwrt-
2::GTA), we first removed the GalK sequences from the
GTA tag vector pMB71 by expression of Flp recombin-
ase. The resulting GFP-2xTEV-Avi sequence was then
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amplified using primers GTA_F (5′-aaaGGTACCggta-
gaaaaaatgagtaaaggagaagaacttttc) and GTA_R (5′-aaaGC-
TAGCttattcatgccattcaatcttctgag), and cloned into vector
pPD158.87 (Addgene #1709) using KpnI and NheI. Next,
promoter regions were amplified from C. elegans gen-
omic DNA and cloned into appropriate restriction sites.
For pMB43, the rps-27 promoter was amplified using
primers Prps-27F (5′-aaaCTGCAGttcaatcggtttttcctt
gcttgc) and Prps-27R (5′-aaaGGTACCattccacttgttgag
cggggctg), and cloned using PstI/KpnI. For pMB76, the
elt-2 promoter was amplified using primers Pelt-2F (5′-
aaaCTGCAGtaatttcgaaatgtatgaactccaattc) and Pelt-2R
(5′-aaaCCCGGGctataatctattttctagtttc), and cloned using
PstI/SmaI. For pMB77, the wrt-2 promoter was amplified
using primers Pwrt-2F (5′-aaaCTGCAGcaggtcgactccacg-
taatttc) and Pwrt-2R (5′-aaaCCCGGGGATCCccgagaaac
aattggcaggttg), and cloned using PstI/SmaI. For pMB43,
the let-858 3′-UTR was replaced with the tbb-2 3′-
UTR by PCR amplifying the tbb-2 3′-UTR with primers
tbb-2U_F (5′-aaaGCTAGCatgcaagatcctttcaagc) and tbb-
2U_R (5′-aaaGGGCCCtgatccacgatctggaagatttc), and clon-
ing using NheI and ApaI restriction sites. Vector maps
and sequences are available in Additional file 16.
C. elegans strains and culture conditions
Unless otherwise indicated, strains were maintained at
15 °C as previously described [73]. Transgenic strains were
generated by injecting constructs into the gonad of young
adult N2 animals using conventional micro-injection pro-
cedures. N2 animals were obtained from the Caenorhabdi-
tis Genetics Center. The amounts of each construct
injected are indicated for each strain, and were supple-
mented to a final DNA concentration of 80 ng/μl with PstI
digested phage λ DNA. The resulting transgenic strains
carrying extrachromosomal arrays were subjected to
gamma irradiation to integrate the construct into the C.
elegans genome. The following strains were generated:
BAT5: barIs3 [Prgef-1::BirA, Pceh-36::mCherry] X
BOX20: mibIs7[Pwrt-2::BirA 10 ng/μl + Pmyo-
2::mCherry 2.5 ng/μl]II
BOX27: mibIs14[Pelt-2::BirA 10 ng/μl + Pmyo-
2::mCherry 2.5 ng/μl]I
BOX41: mibIs23[lgl-1::GFP-2xTEV-Avi 10 ng/μl, Pmyo-
3::mCherry 5 ng/μl]V
BOX43: mibIs25[Avi-2xTEV-GFP::cdc-42 10 ng/μl,
Pmyo-3::mCherry 5 ng/μl]X
BOX51: mibIs26[par-3::GFP-2xTEV-Avi 10 ng/μl,
Pmyo-3::mCherry 5 ng/μl]V
BOX55: mibIs30[let-413::GFP-2xTEV-Avi 10 ng/μl,
Pmyo-3::mCherry 5 ng/μl]X
BOX56: mibIs31[dlg-1::GFP-2xTEV-Avi 10 ng/μl,
Pmyo-3::mCherry 5 ng/μl]V
BOX58: mibIs33[Prps-27::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I
BOX60: mibIs35 [Prgef-1::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl] II
BOX61: mibIs36[Pwrt-2::GFP-2xTEV-Avi 10 ng/μl,
Prab-3::mCherry 5 ng/μl]X
BOX62: mibIs37[Pelt-2::GFP-2xTEV-Avi 10 ng/μl,
Prab-3::mCherry 5 ng/μl]X
BOX65: mibIs40[Prps-27::GFP-2xTEV-Avi 10 ng/μl,
Prab-3::mCherry 5 ng/μl]III
BOX99: mibIs14[Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs37[Pelt-2::GFP-2xTEV-Avi
10 ng/μl, Prab-3::mCherry 5 ng/μl]X
BOX100: mibIs7[Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]II; mibIs37[Pelt-2::GFP-2xTEV-Avi
10 ng/μl, Prab-3::mCherry 5 ng/μl]X
BOX101: mibIs14[Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs36[Pwrt-2::GFP-2xTEV-Avi
10 ng/μl, Prab-3::mCherry 5 ng/μl]X
BOX102: mibIs7[Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]II; mibIs36[Pwrt-2::GFP-2xTEV-Avi
10 ng/μl, Prab-3::mCherry 5 ng/μl]X
BOX103: mibIs33[Prps-27::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs26[par-3::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V
BOX104: mibIs7[Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]II; mibIs26[par-3::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V
BOX105: mibIs14[Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs26[par-3::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V
BOX106: mibIs33[Prps-27::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs31[dlg-1::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V; dlg-1(ok318)X
BOX107: mibIs7[Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]II; mibIs31[dlg-1::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V; dlg-1(ok318)X
BOX108: mibIs14[Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs31[dlg-1::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V; dlg-1(ok318)X
BOX109: mibIs35 [Prgef-1::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl] II; mibIs31 [dlg-1::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 10 ng/μl] V ; dlg-1(ok318) X
BOX110: mibIs33[Prps-27::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs30[let-413::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]X
BOX111: mibIs7[Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]II; mibIs30[let-413::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]X
BOX112: mibIs14[Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs30[let-413::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]X
BOX113: mibIs33[Prps-27::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs23[lgl-1::GFP-2xTEV-
Avi 10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V; lgl-
1(tm2616)X
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BOX114: mibIs7[Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]II; mibIs23[lgl-1::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V; lgl-1(tm2616)X
BOX115: mibIs14[Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs23[lgl-1::GFP-2xTEV-Avi
10 ng/μl, Pmyo-3::mCherry 5 ng/μl]V; lgl-1(tm2616)X
BOX116: mibIs40[Prps-27::GFP-2xTEV-Avi 10 ng/μl,
Prab-3::mCherry 5 ng/μl]III; mibIs33[Prps-27::BirA
10 ng/μl, Pmyo-2::mCherry 2.5 ng/μl]I
BOX117: mibIs7[Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]II; mibIs40[Prps-27::GFP-2xTEV-
Avi 10 ng/μl, Prab-3::mCherry 5 ng/μl]III
BOX118: mibIs14[Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl]I; mibIs40[Prps-27::GFP-2xTEV-Avi
10 ng/μl, Prab-3::mCherry 5 ng/μl]III
BOX119: mibIs35 [Prgef-1::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl] II; mibIs40 [Prps-27::GFP-2xTEV-
Avi 10 ng/μl, Prab-3::mCherry 5 ng/μl] III
BOX133: mibIs7 [Pwrt-2::BirA 10 ng/μl, Pmyo-
2::mCherry] II; mibIs25 [cdc-42::GFP-2TEV-Avi 10 ng/μl,
Pmyo-3::mCherry 10ngμl] X
BOX134: mibIs33 [Prps-27::BirA 10 ng/μl, Pmyo-
2::mCherry 2.5 ng/μl] I; mibIs25 [cdc-42::GFP-2TEV-Avi
10 ng/μl, Pmyo-3::mCherry 10 ng/μl] X
BOX135: mibIs14 [Pelt-2::BirA 10 ng/μl, Pmyo-
2::mCherry 10 ng/μl] I; mibIs25 [cdc-42::GFP-2TEV-Avi
10 ng/μl, Pmyo-3::mCherry 10 ng/μl] X
BOX188: maph-1.1(mib12[GFP::maph-1.1]) I
BOX209: maph-1.1(mib12[GFP::maph-1.1]) I; mibIs35
[Prgef-1::BirA 10 ng/μl, Pmyo-2::mCherry 2.5 ng/μl] II;
mibIs40 [Prps-27::GFP-2xTEV-Avi 10 ng/μl, Prab-
3::mCherry 5 ng/μl] III
BOX212: maph-1.1(mib12[GFP::maph-1.1]) I; mibIs35
[Prgef-1::BirA 10 ng/μl, Pmyo-2::mCherry 2.5 ng/μl] II;
mibIs31 [dlg-1::GFP-2xTEV-Avi 10 ng/μl, Pmyo-
3::mCherry 10 ng/μl] V
SV1311: atad-3(ok3093) II; hels97[Patad-3::ATAD-3,
cb unc-119] IV (referred to as ATAD-3FL)
SV1312: atad-3(ok3093) II; hels98[atad-3::ATAD-3-
ETAV, cb unc-119] IV (referred to as ATAD-3ΔETAV).
Western blot analysis
Protein samples were separated on 10 % acrylamide gels,
and subjected to western blotting on polyvinylidene difluor-
ide membrane (Immobilon-P; Millipore). Blots were
blocked with 5 % skim milk in phosphate-buffered saline
with Tween (PBST; 7 mM Na2HPO4, 3 mM NaH2PO4,
140 mM NaCl, 5 mM KCl, 0.05 % Tween-20) for 1 h at
room temperature. For detection of GFP, blots were incu-
bated with rabbit polyclonal anti-GFP (Abcam ab6556,
1:1000) or anti-biotin (Abcam ab1227, 1:1000) in PBST +
5 % skim milk for 1 h at room temperature, washed with
PBST three times for 10 min each at room temperature, in-
cubated with anti-rabbit IgG antibody conjugated to
horseradish peroxidase (Jackson Immuno Research
111035003, 1:10,000) for 45 min at room temperature,
washed with PBST three times for 10 min each at room
temperature, and finally washed once with PBS at room
temperature for 10 min. Blots were developed using en-
hanced chemiluminescent western blotting substrate (Bio-
Rad Laboratories).
C. elegans liquid culture
Liquid cultures were started with semi-synchronized L1
animals obtained by starvation. Depending on the growth
rate of the transgenic strain to be cultured, 20–60 9 cm
nematode growth media (NGM) plates with OP50 bac-
teria were seeded with 15–45 L4 animals per plate. After 6
or 7 days at 20 °C, no bacteria were left on the plates and
the plates were covered with starved L1 animals. All ani-
mals were washed off the plates and transferred to a 2 l
Erlenmeyer flask containing 500 ml S-medium supple-
mented with penicillin-streptomycin (5000 U/ml, Life
Technologies 15070-63) diluted 1:100, and nystatin sus-
pension (10,000 U/ml, Sigma N1638) diluted 1:1000 [74].
A pellet of OP50 E. coli bacteria obtained from a 0.5 l
overnight culture in lysogeny broth (LB) was added as
food source. Animals were allowed to develop until the
L3/L4 stage in an incubator at 20 °C shaking at 200 rpm.
To harvest the animals, the culture was transferred to
50 ml conical tubes and cooled on ice for 20 min. Animals
were then pelleted by centrifugation (all centrifugation
steps in this protocol were performed at 400 g for 2 min
at 4 °C). After aspirating the supernatant, animals were
pooled in a single 50 ml tube, and washed twice in ice-
cold M9 lacking MgSO4 [74]. After the second wash step,
animals were resuspended in 20 ml of ice-cold M9 lacking
MgSO4, followed by the addition of 20 ml of ice-cold 60 %
sucrose in H2O. After vigorous mixing of the sucrose/
worm mixture, 4 ml of ice-cold M9 lacking MgSO4 was
gently layered on top, and the worms were centrifuged at
400 g for 2 min at 4 °C. A layer of animals was now visible
on top of the sucrose, while contaminants sedimented at
the bottom. The sucrose float steps were performed as
quickly as possible, as otherwise the layer of animals failed
to form properly. To maximize recovery, 30 ml of super-
natant was aspirated from the sucrose float, and distrib-
uted into four 50 ml tubes that were subsequently filled by
addition of room-temperature M9 lacking MgSO4. The
room temperature M9 allowed the animals to digest OP50
bacteria in their intestine. The four tubes were placed on
ice to cool down for 30 min, after which the animals were
washed twice in lysis buffer (150 mM NaCl, 20 mM Tris
pH 7.8, 5 mM EDTA). During the first wash the animals
were again pooled into one tube. After a final wash in lysis
buffer supplemented with 1 % Triton X-100, as much lysis
buffer as possible was removed, and the C. elegans pellet
was frozen in liquid nitrogen and stored at −80 °C.
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Lysis
C. elegans pellets were lysed by sonication using a
Diagenode Bioruptor (http://www.diagenode.com) fitted
with a 15 ml tube holder. To each frozen pellet was added
5 ml of lysis buffer (150 mM NaCl, 20 mM Tris pH 7.8,
5 mM EDTA) supplemented with 1 % Triton X-100, 0.5
tablet of protease inhibitor (Roche, 05892791001), and
7 μl of β-mercaptoethanol. Pellets were gently swirled
until thawed. Lysates were transferred to 15 ml TPX hard
plastic tubes and placed in the Bioruptor filled with ice-
water. Samples were lysed nine times for 30 s, with 30 s
intervals. After the third and sixth lysis period, lysates
were mixed by gently swirling the tube. To remove
cellular debris, lysates were distributed to 2 ml
Eppendorf tubes, centrifuged at 16,000 g for 15 min
at 4 °C, and collected in a fresh conical-bottom
15 ml polypropylene tube. The concentration of pro-
tein in the lysates was determined by Bradford assay
(Bio-Rad Laboratories) and the lysates were diluted to
1 mg protein/1 ml lysate.
Affinity purification
Affinity purifications were performed with streptavidin-
coated beads (Chromotek, HP57.1). Prior to use, beads
were washed twice in lysis buffer (150 mM NaCl,
20 mM Tris pH 7.8, 5 mM EDTA) supplemented with
1 % Triton X-100 in a 1.5 ml Eppendorf tube, pelleting
the beads by centrifugation at 7500 g for 30 s. After the
final wash, beads were resuspended in lysis buffer, in the
original volume. Next, 25 μl of beads were added to
15 ml of lysate (15 mg protein) in a 15 ml conical-
bottom polypropylene tube, after which the tubes were
rotated at 4 °C for 1.5 h. Following the incubation, beads
were pelleted by centrifugation at 3220 g for 5 min at 4 °
C, resuspended in 0.5 ml TEV buffer (20 mM Tris
pH 8.0, 150 mM NaCl, and 0.3 % NP40), and transferred
to an Eppendorf tube. Beads were then washed three
times with 500 μl TEV buffer, pelleting the beads by cen-
trifugation at 7500 g for 30 s at 4 °C. Finally, the beads
were resuspended in 15 μl TEV buffer and 2 μl of TEV
protease (Promega, V6101) was added to the samples.
TEV cleavage was performed overnight at 4 °C in a shak-
ing block for Eppendorf tubes, shaking at 800 rpm.
Mass spectrometry
Protein reduction and alkylation was performed with
10 mM dithiothreitol (56 °C for 1 h) and 50 mM 2-
chloro-iodoacetamide (30 min at room temperature in
the dark), respectively, after which in-gel digestion was
performed with trypsin overnight at 37 °C. Peptides were
extracted with 100 % acetonitrile. The samples were ana-
lyzed on an LTQ Orbitrap Elite (Thermo Scientific, Bre-
men) connected to a Proxeon UHPLC system (Thermo
Scientific, Odense). The nanoLC was equipped with a
20 mm × 100 μm internal diameter Reprosil C18 trap
column and a 400 mm × 50 μm internal diameter Poro-
shell C18 analytical column (Zorbax, Agilent), all packed
in-house. Solvent A consisted of 0.1 M acetic acid
(Merck) in deionized water (Milli-Q, Millipore), and
solvent B consisted of 0.1 M acetic acid in 80 % aceto-
nitrile (Biosolve). Trapping was performed at a flow of
5 μl/min for 10 min and the fractions were eluted using
a flow rate of 150 nl/min (120 min LC method). The
mass spectrometer was operated in positive ion mode
and in data-dependent mode to automatically switch be-
tween MS and MS/MS. The three most intense ions in
the survey scan (350–1500 m/z, resolution 60,000, AGC
target 1e6) were fragmented with higher energy colli-
sional dissociation (HCD; AGC target 6e4), with the nor-
malized collision energy set to 32 %. The signal
threshold for triggering an MS/MS event was set to 500
counts. Charge state screening was enabled, and precur-
sors with unknown charge state or a charge state of 1
were excluded. Dynamic exclusion was enabled (exclu-
sion size list 500, exclusion duration 40 s).
Mass spectrometry data analysis
Peak lists were generated from the raw data files using
Proteome Discoverer version 1.4.1.14 (Thermo Scien-
tific, Bremen). For each affinity purification, one peak list
was generated per gel lane. Peak lists were searched
against a C. elegans database (UniProt, Jan 2014, 25,863
entries) supplemented with frequently observed contam-
inants using Mascot software version 2.4.01 (Matrix Sci-
ence, UK). Trypsin was chosen with two missed
cleavages allowed. Carbamidomethylation (C) was set as
a fixed modification and oxidation (M) was set as vari-
able modification. The searches were performed using a
peptide mass tolerance of 50 ppm and a product ion tol-
erance of 0.05 Da (HCD), followed by data filtering using
percolator, resulting in 1 % false discovery rate (FDR).
Only ranked 1 peptide spectrum matches with Mascot
scores >20 were accepted. The spectral counts for each
triplicate of controls and the four tissues were uploaded
to the CRAPome online interface version 1.1 [42] for
statistical validation.
Lysis and immunoprecipitations for DLG-1/ATAD-3
Strains were grown in S-medium, either containing
HB101 bacteria or bacterial feeding strains targeting dlg-
1, atad-3, or gfp (control) to induce RNAi. Embryo pel-
lets were obtained by hypochlorite treatment of adult
worms. Embryo pellets were ground two times for 30 s
at a frequency of 1500 beats/min using a Mikro-
Dismembrator (Sartorius). Ground embryo pellets were
lysed in lysis buffer [20 mM Tris-HCl pH 7.8, 250 mM
NaCl, 15 % glycerol, 1 % Triton X-100, 0.5 mM EDTA,
1 mM β-mercaptoethanol, 10 mM 1-naphthyl phosphate
Waaijers et al. BMC Biology  (2016) 14:66 Page 18 of 24
monosodium salt monohydrate, 50 mM sodium fluoride,
10 mM sodium pyrophosphate decahydrate, 100 μM so-
dium orthovanadate, and protease inhibitors (Roche
complete, Mini, EDTA-free)] for 15 min at 4 °C. The lys-
ate was cleared at 13,000 rpm for 15 min at 4 °C. For
immunoprecipitations, 1 mg of total protein was used
with either 1 μl mouse anti-PSD95 antibody (Abcam
ab2723, RRID AB_303248) non-covalently bound to 5 μl
protein G Sepharose beads, 1 μl rabbit anti-ATAD-3
antibody [44] non-covalently bound to 7.5 μl protein A
Sepharose beads, 2 μl rabbit anti-GFP antibody (Ther-
moFisher A-11122, RRID AB_10073917) non-covalently
bound to 7.5 μl protein A Sepharose beads (negative
control), or 2 μl rabbit anti-eIF4E antibodies [75] non-
covalently bound to 7.5 μl protein A Sepharose beads
(negative control). Immunoprecipitations were per-
formed for 1 h at 4 °C. Input lysates (1/25) and immuno-
precipitations were loaded on gel. Standard procedures
were used for SDS-PAGE and western blotting. Mouse
anti-PSD95 (1:1000) and rabbit anti-ATAD-3 (1:500)
were used for detection. Horseradish peroxidase-
conjugated protein A (VWR International) was used at
1:5000 for ATAD-3 probed blots. The signal was re-
vealed with chemiluminesence (Bio-Rad Laboratories).
To examine protein levels in ATAD-3FL, and ATAD-
3ΔETAV strains, 40 L4 staged larvae grown at indicated
temperatures were collected and boiled for 5 min in 1 ×
Laemmli sample buffer. Samples were run on an SDS-
PAGE gel, and blotted according to standard procedures.
Immunoblots were probed with rabbit anti-ATAD-3
(1:500) and mouse anti-actin (1:1000) (MP Biomedicals).
Immunoprecipitations for DLG-1/MAPH-1.1
Animals were grown and lysed, and GTA-tagged pro-
teins were purified as described above for the MS exper-
iments. Input lysates (1/100) and immunoprecipitations
were loaded on gel. Standard procedures were used for
SDS-PAGE and western blotting. For detection of GFP,
blots were incubated with rabbit polyclonal anti-GFP
(Abcam ab6556, 1:1000) in PBST + 5 % skim milk for
1 h at room temperature, washed with PBST three times
for 10 min at room temperature, incubated with anti-
rabbit IgG antibody conjugated to horseradish peroxid-
ase (Jackson Immuno Research 111035003, 1:10,000) for
45 min at room temperature, washed with PBST three
times for 10 min at room temperature, and finally
washed once with PBS at room temperature for 10 min.
Yeast two-hybrid assays
To generate DB::DLG-1 and DB::BAZ fusions, relative
fragments were PCR amplified with primers containing
EcoRI and BamHI restriction sites in their tails, and
cloned into vector pGBTK7 (Clontech, Palo Alto, CA,
USA). The following primers were used: PDZ1_F (5′-
agGAATTCgtcttggagaaaggtcac), PDZ1_R (5′-tggtggGGA
TCCcggagccgatgg), PDZ2_F (5′-tccatcgGAATTCattcatcc
acc), PDZ2_R (5′-tcccatGGATCCgcggttgtag), PDZ3_F
(5′-gactacGAATTCtctcaaatgg), PDZ3_R (5′-atGGATCC
ctcttgtggtctgtactg), BAZ_PDZ1-3_F (5′-tgGAATTCgagagc
aagcgaaaggagccc), and BAZ_PDZ1-3_R (5′-gcGGATCC
caagatcttgcggcctaccagc).
To generate AD∷ATAD-3 aa388-595 and AD::ATAD-3
aa388-591 (ΔETAV) fusions, relative fragments were PCR
amplified with primers containing BamHI and XhoI re-
striction sites in their tails, and cloned into vector pACT2
(Clontech). The following primers were used: ATAD-3_F
(5′-tcggcGGATCCcaattcataaag), ATAD-3_R595 (5′-taaac
CTCGAGttaaacagcagtttctctcttc), and ATAD-3_R591 (5′-
taaacCTCGAGttatctcttcaacgta). DB and AD plasmids
were co-transformed into yeast strain Y190 (Clontech)
using the LiAc transformation method [76]. For X-gal as-
says, yeast were grown overnight at 30 °C on a nitrocellu-
lose filter on top of a yeast extract peptone dextrose
(YEPD) agar plate. A Whatman filter paper was placed in
a petri dish containing 2 ml of Z-buffer (60 mM
Na2HPO4, 40 M NaH2PO4, 10 M KCl, 1 M MgSO4,
pH 7), 5.4 μl β-mercaptoethanol, and 33.4 μl X-Gal (stock
solution 20 mg/ml in N,N-dimethyl formamide). The
nitrocellulose filter with yeast was then fixed in liquid ni-
trogen for 10 s, thawed at room temperature, and placed
on the Whatman filter paper for 30 min at 30 °C.
Generation of atad-3 transgenic strains
For MosSCI integration of atad-3 constructs on
chromosome IV, we generated Patad-3::atad-3::atad-3
3′UTR and Patad-3::atad-3ΔETAV::atad-3 3′UTR con-
structs, and cloned these into the pCFJ1178 vector (a gift
from E. Jorgensen, HHMI, University of Utah, USA). For
Patad-3 we used a 1050 bp 5′ region of atad-3. As a 3′
UTR we used a 300 bp flanking region of atad-3. Patad-
3::atad-3-ETAV::atad-3 3′UTR lacked 12 bp at the 3′-
end of the coding region. MosSCI integration was per-
formed as previously described [46, 77]. Briefly: the fol-
lowing injection mixture was injected into unc-119
animals: 10 ng/μl targeting vector, 10 ng/μl pCFJ601
(Peft-3:Mos1 transposase), 2.5 ng/μl pCFJ90 (Pmyo-
2:mCherry:unc-54 UTR), and 10 ng/μl pGH8 (Prab-
3:mCherry:unc-54 UTR), and wild-type non-fluorescent
animals were selected from the F2 progeny.
Progeny counting and scoring of embryonic lethality
Starting at the L4 stage, individual animals were cultured at
15 °C or 25 °C and transferred to a fresh plate every 24 h.
Hatched and unhatched progeny were counted 24 h after
removal of the P0. Bars in Fig. 6 represent mean values,
and error bars the standard deviation. The progeny of four
animals was counted for each genotype and temperature.
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Phylogenetic analysis and protein alignments
To identify proteins related to MAPH-1.1, MAPH-1.2,
and MAPH-1.3, we performed an iterative JackHMMER
search with each of the three proteins against the Refer-
ence Proteomes dataset (three iterations). To generate
the phylogenetic tree, we selected MAP1 homologs from
a subset of species. These sequences were aligned using
the online version of MAFFT with the settings E-INS-i
iterative refinement method (http://mafft.cbrc.jp/align-
ment/server/) [78]. From the aligned sequences, a phylo-
genetic tree was produced using FastTree 2 with the
default settings [79]. The online Interactive Tree of Life
tool was used to visualize the phylogenetic tree (http://
itol.embl.de/) [80]. To calculate similarity of MAPH-1.1
to human MAP1S and Drosophila Futsch, we performed
pairwise alignments with MAFFT as described above,
and calculated protein similarity using the online Se-
quence Manipulation Suite (http://www.bioinformatic-
s.org/sms2/ident_sim.html) [81].
Genome engineering of GFP::maph-1.1
To engineer the GFP::maph-1 locus, we used homology
directed repair of a CRISPR/Cas9 induced double strand
break (DSB). To increase the efficiency of DSB generation
we generated a new subgenomic RNA (sgRNA) expression
vector (pJJR50) that contains the A-U flipped and hairpin
extended sgRNA sequence described in Chen et al. [82],
under control of the R07E5.16 U6 promoter [83]. Target
sequences are cloned into BbsI digested vector as pairs of
annealed oligonucleotides with a 5′-TCTT overhang
added to the forward oligo, and a 5′-AAAC overhang
added to the reverse oligo. The maph-1.1 sgRNA target
sequence was GCGTGCATCTACGTCTTGGG, and oli-
gos used to insert the sequence into pJJR50 were 5′-
tcttGCGTGCATCTACGTCTTGGG and 5′- aaacCC-
CAAGACGTAGATGCACGC. To generate the repair
template, we inserted 450–650 bp sequences flanking the
start codon of maph-1.1 into the self-excising selection
cassette vector pDD282 as described [84]. Several muta-
tions were introduced into the sgRNA target site to pre-
vent cutting by Cas9 after repair. The following mixture
was injected into 20 N2 adults: 50 ng/ml Peft-3::Cas9
(Addgene #46168) [85], 100 ng/ml sgRNA in pJJR50,
20 ng/ml maph-1.1 repair template, and 2.5 ng/ml pCFJ90
[46]. Injected animals were placed on individual NGM
plates. After 2–3 days at 25 °C, 500 μl of 5 mg/ml hygro-
mycin in water was added to each plate, and healthy non-
red-fluorescent Rol animals were selected after 3–5 days.
To eliminate the marker cassette, 8–16 L2 animal were
heat shocked for 4 h at 34 °C, and non-Rol progeny were
selected. We obtained two independent lines, both of
which displayed the same expression pattern. Vector maps
and sequences are available in Additional file 16.
Expression in hippocampal neurons and fixation
To express MAPH-1.1 and DLG-1 in hippocampal neu-
rons, we generated constructs consisting of MAPH-
1.1 N-terminally tagged with GFP, and DLG-1 C-
terminally tagged with mCherry, driven by the βactin
promoter. MAPH-1.1 and DLG-1 were PCR amplified
from a mixed-stage C. elegans cDNA library, and
inserted into a vector containing the pβactin promoter
and GFP or mCherry [86]. MAPH-1.1 was amplified
using primers 5′-aaaGGCGCGCCAatgccggaggaatatatc
atg and 5′-tttGCGGCCGCttagagcaaatcgactctggcc, and
cloned using AscI and NotI. DLG-1 was amplified using
primers 5′-aaaAAGCTTatgtcccacgagtcatcgg and 5′-
tttGGTCTCGTCGACttatgacgtggcacccaaattggcg,
digested with HindIII and BsaI, and ligated into vector
digested with HindIII and SalI. Vector maps and se-
quences are available in Additional file 16. Primary hip-
pocampal neurons prepared from embryonic day 18 rat
brains [86] were transfected at 4 days in vitro (DIV4) for
MAPH-1 and microtubule imaging, or DIV22 for DLG-1
imaging, using Lipofectamine 2000 (Life Technologies)
and cultured for 2 additional days. For microtubule im-
aging, cells were first extracted with 0.3 % glutaraldehyde
(GA) in PEM80-buffer (80 mM PIPES, 1 mM EGTA,
4 mM MgCl2, pH 6.9) for 1 min at 37 °C. Next, fixation
was performed in 4 % paraformaldehyde (PFA) for
10 min. Subsequently, cells were washed twice for 5 min
in PBS (Lonza BE17-517Q, w/o Ca and Mg) and cells were
further permeabilized for 10 min in PBS + 0.2 % Triton-
X100. Cells were then washed three times for 5 min in
PBS and incubated for 45 min in blocking solution
(2 % w/v bovine serum albumin [BSA], 0.2 % w/v gelatin,
10 mM glycine, 50 mM NH4Cl in PBS, pH 7.4). Primary
antibodies to α-tubulin (Sigma, mouse clone B-5-1-2,
1:800) and MAP2 (Abcam ab5392, chicken, 1:1000) were
incubated overnight at 4 °C in blocking solution. Cells
were washed three times in PBS and incubated with sec-
ondary antibodies anti-Mouse Alexa Fluor568 (Life Tech-
nologies, goat, 1:800) and anti-Chicken Alexa Fluor647
(Life Technologies, goat, 1:800) for 1.5 h at room
temperature. Finally, cells were washed three times in PBS
and mounted in Mowiol 4-88 (Sigma-Aldrich). For im-
aging of postsynaptic densities, fixation (without prior ex-
traction) was performed in 4 % PFA for 10 min.
Subsequently, cells were washed three times for 10 min in
PBS (Lonza BE17-517Q, w/o Ca and Mg), and mounted
in Mowiol 4-88.
Microscopy and image processing
Still images of live animals were captured on a spinning
disc platform consisting of a Nikon Ti-U inverted micro-
scope with a motorized XY stage and a Piezo Z stage, ×60
and × 100 PLAN APO 1.4 numerical aperture (NA) oil ob-
jectives, a Yokogawa CSU-X1 spinning disc unit equipped
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with a dual dichroic mirror set for laser wavelengths
488 nm and 561 nm, 488 nm and 561 nm solid state
50 mW lasers controlled by an Andor revolution 500 series
AOTF Laser modulator and combiner, Semrock 512/23 +
630/91 dual band pass emission filter, Semrock 525/30 sin-
gle band pass emission filter, Semrock 617/73 single band
pass filter, Semrock 4800 long pass filter (500–1200 pass),
and an Andor iXON DU-885 monochrome EMCCD+
camera. All components were controlled by MetaMorph
Microscopy Automation & Image Analysis Software. Live
imaging was performed on a Nikon Eclipse-Ti microscope
with a Plan Apo VC, ×60, 1.40 NA oil objective (Nikon).
The microscope was equipped with an ASI motorized stage
MS-2000-XYZ with Piezo Top Plate and a Perfect Focus
System (Nikon), and used MetaMorph 7.8 to control the
camera and all motorized parts. Confocal excitation and de-
tection was achieved using a 100 mW Cobolt Calypso laser,
Yokogawa spinning disc confocal scanning unit (CSU-X1-
A1), a GFP emission filter [ET-GFP (49002); Chroma], and
a Photometrics Evolve 512 EMCCD camera at a final mag-
nification of 110 nm per pixel, including an additional mag-
nification introduced by an extra intermediate lens 2.0X
(Edmund Optics). For FRAP experiments we used a simi-
lar microscope setup equipped with an ILas system (Roper
Scientific France/PICT-IBiSA, Institut Curie), with the
laser set at 100 % laser power and a Plan Apo × 60 NA
1.40 oil lens. Imaging was performed at 1 or 2 frames per
second. Microscopy of fixed samples was performed on a
Zeiss LSM700 laser scanning confocal microscope
equipped with a × 63 Plan-Apochromat 1.4 NA objective;
405 nm, 488 nm, 555 nm, and 633 nm lasers; and the fol-
lowing emission filters: SP490 (400–490 nm), SP555
(400–555 nm), SP640 (400–640 nm), BP490-555 (490–
555 nm), LP560 (560–750 nm), LP640 (640–750 nm), and
BP592-662 (592–662 nm). The LSM700 was controlled by
the Zen software package. Maximum projections were
generated from a series of slices of a Z-stack with ImageJ
and processed with Adobe Photoshop CS6 and Adobe Il-
lustrator CS6.
FRAP analysis
Images were processed and analyzed in ImageJ. For the
FRAP analysis, the average gray value of a 100 × 10 pixel
region in the FRAP region or a similar non-bleach area
was calculated and background subtracted frame-by-
frame by subtracting the average intensity of an empty,
non-bleached area. FRAP recovery was calculated as the
recovery from the first frame after bleach (set to 0) nor-
malized to the average of the five frames before bleach.
Microtubule depolymerization speed measurement
Microtubule depolymerization speeds were calculated by
making kymographs of the acquired movies using the
KymoResliceWide plugin in ImageJ and measuring the
distance and time of a depolymerization event. Graphs in
Additional file 15: Figure S6 show the mean ± standard de-
viation, as well as individual measurements.
Additional files
Additional file 1: Figure S1. C. elegans optimized BirA. a DNA
sequence of BirA, codon optimized for C. elegans and including four
artificial introns, as well as a Myc tag. b Analysis of the expression and
splicing of BirA expressed from the neuronal rgef-1 promoter by RT-PCR.
Primer locations relative to the BirA coding sequence are indicated. Each
RT-PCR results in a band with the expected size for a properly expressed
and spliced BirA cDNA. (PDF 195 kb)
Additional file 2: Figure S2. DNA sequence of the C-terminal GTA tag.
Relevant regions are highlighted in color. (PDF 88 kb)
Additional file 3: Figure S3. DNA sequence of the N-terminal GTA tag.
Relevant regions are highlighted in color. (PDF 88 kb)
Additional file 4: Table S1. All proteins identified, organized by tissue
examined. (XLSX 118 kb)
Additional file 5: Table S2. All proteins identified, organized by bait
protein. (XLSX 140 kb)
Additional file 6: Table S3. Expanded copy of Table 2 in the main text
including peptide numbers. (XLSX 14 kb)
Additional file 7: Figure S4. ATAD-3FL and ATADΔETAV are expressed at
similar levels. Western blot analysis showing expression levels of ATAD-3
in ATAD-3FL and ATADΔETAV transgenic animals at three different temper-
atures. (PDF 244 kb)
Additional file 8: Figure S5. a Phylogenetic tree of MAP1-related pro-
teins. Proteins were identified through iterative HMMER searches as im-
plemented in JackHMMER. Three major groups containing the human
MAP1A, MAP1B, and MAP1S proteins are color coded. b Sequence align-
ment of MAPH-1.1 with human MAP1A. (PDF 231 kb)
Additional file 9: Movie S1. Live imaging of GFP::MAPH-1.1 in body
wall muscle cells. (MP4 4269 kb)
Additional file 10: Movie S2. Live imaging of GFP::MAPH-1.1 in the
hypodermis. (MP4 2275 kb)
Additional file 11: Movie S3. Live imaging of GFP::MAPH-1.1 in head
region showing nerve ring. (MP4 2266 kb)
Additional file 12: Movie S4. Live imaging of GFP::MAPH-1.1 in
posterior pharynx bulb. (MP4 2252 kb)
Additional file 13: Movie S5. Live imaging of GFP::MAPH-1.1 in seam
cells. (MP4 2276 kb)
Additional file 14: Movie S6. Example of FRAP analysis in hypodermis.
(MP4 3024 kb)
Additional file 15: Figure S6: GFP::MAPH-1 dynamics. a Fluorescence
recovery of GFP::MAPH-1.1 after photobleaching in the hypodermis.
Shown is the mean ± SEM of seven measurements. Dotted horizontal line
indicates the maximum recovery (average of the final 10 time points,
0.724). Dotted vertical line indicates the time point (6 s) of 50 % recovery
of the maximum. See Additional file 14: Movie S6 for an example. b
Microtubule depolymerization rates in the hypodermis (Hyp) and body
wall muscle (BWM). Shown is the mean ± SD, as well as individual
measurements. Hyp n = 14, BWM n = 18. (PDF 139 kb)
Additional file 16: PDF document with all vector maps and sequences.
(PDF 1724 kb)
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